Letter to the Editor
Including Mood in the Proposed Criteria for Refractory Migraine
- Conflict of Interest: Dr. Schulman has served as a consultant to NuPathe and Zogenix. He is on the speakers' bureau of Merck and Impax. He has received research funding from NuPathe and has received royalties from Oxford University Press.
No abstract is available for this article.